骨科生物製劑市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球骨科生物製品市場規模為61億美元，從2023年的64.3億美元成長到2031年的98.7億美元，在預測期內（2024-2031年）預計將以5.5%的複合年成長率成長。

由於幾個關鍵因素，預計骨科生物製劑市場將在預測期內顯著成長。運動傷害和道路事故發生頻率的增加是預計推動市場擴張的兩個重要因素。此外，脊椎疾病和病症發病率的增加預計將有助於市場成長。此外，患者對微創治療的偏好增加也可能支持市場擴張，而與基於骨科生物製劑的治療相關的高成本可能會成為市場限制。此外，老年人和肥胖人口的增加也是市場的順風車，進一步加速了需求。骨生物製劑，也稱為再生細胞療法，由含有生長因子的產品組成，不僅可以緩解不適，還可以促進組織癒合並幫助恢復正常功能。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 供應鏈分析
• 市場生態系統
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

骨科生物製品市場：依產品

• 市場概況
• 關節內粘稠補充療法產品
• 去礦物質骨基質
• 合成骨科生物製劑
• 骨形成蛋白
• 同種異體移植
• 血漿蛋白
• 骨髓抽吸濃縮液

骨科生物製品市場：依應用分類

• 市場概況
• 骨關節炎和退化性關節炎
• 脊椎融合手術
• 軟組織損傷
• 骨折恢復
• 顎顏面和牙科應用

骨科生物製品市場：依最終使用者分類

• 市場概況
• 醫院、整形外科診所、門診治療中心
• 研究/學術機構
• 牙科診所和設施

骨科生物製劑市場規模：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic PLC
• Stryker Corporation
• Globus Medical, Inc.
• Orthofix International NV
• RTI Surgical, Inc.
• Kuros Biosciences Ltd.
• Bioventus LLC
• Nuvasive, Inc.
• Seaspine Holdings Corporation
• Arthrex, Inc.
• Xtant Medical Holdings, Inc.
• Smith & Nephew plc
• Sanofi SA
• Integra LifeSciences Holdings Corporation
• Anika Therapeutics, Inc.
• Alphatec Spine, Inc.
• Orthocell Ltd.
• MiMedx Group, Inc.
• Orthofix Medical Inc.
• Bone Therapeutics SA

Global Orthobiologics Market size was valued at USD 6.1 billion in 2022 and is poised to grow from USD 6.43 billion in 2023 to USD 9.87 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The orthobiologics market is expected to experience significant growth during the forecast period, driven by several key factors. The increasing frequency of sports injuries and traffic accidents are two prominent factors anticipated to fuel market expansion. Additionally, the rising incidence of spinal diseases and disorders is projected to contribute to the market's growth. Furthermore, the growing patient preference for minimally invasive procedures is likely to support market expansion, though this may be tempered by the high costs associated with orthobiologics-based treatments, which could act as a restraint. The market is also benefiting from the growing elderly and obese population, which further accelerates demand. Orthobiologics, also known as regenerative cellular therapies, comprise products containing growth factors that not only alleviate discomfort but also promote tissue healing and help restore normal function.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segmental Analysis

Global Orthobiologics Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate. Based on Application, the market is segmented into Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications. Based on End User, the market is segmented into Hospitals, Orthopedic Clinics, & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Orthobiologics Market

Viscosupplements are in high demand and are expected to significantly contribute to the growth of the orthobiologics market. Knee osteoarthritis, a common issue among the elderly, is extensively treated with viscosupplements, which are hyaluronic acid injections administered directly into the joints. The expansion of the viscosupplements segment is driven by factors such as high product costs, the entry of new manufacturers, and recent marketing approvals. Additionally, the segment is benefiting from improved reimbursement policies, further enhancing its growth prospects. Given these factors, the increasing demand for viscosupplements is anticipated to drive the expansion of the global orthobiologics market during the forecast period.

Restraints in the Global Orthobiologics Market

The growing patient preference for minimally invasive procedures is expected to present challenges to the expansion of the orthobiologics market. Additionally, the market may face further difficulties due to the adverse effects associated with BMP-based therapy. Another significant constraint is the surging prices of orthobiologics-based treatments, which may hinder market growth throughout the forecast period. The complex synthesis processes, stringent manufacturing regulations, and high production costs further limit market expansion. Moreover, the high costs associated with orthobiologics products and treatments, coupled with inadequate reimbursement policies, are major obstacles impeding the growth of the global orthobiologics market.

Market Trends of the Global Orthobiologics Market

The global orthobiologics market is expected to grow significantly, driven by the high prevalence of sports-related injuries. For example, a study titled "Results on Sports-Related Injuries in Children from NHS Emergency Care Dataset Oxfordshire Pilot: An Ecological Study," published in November 2018, revealed that 47.4 percent of emergency department visits related to sports injuries involved children aged 0 to 19, and approximately 23.5 percent of all age groups' admissions were due to sports injuries. However, the cost of orthobiologics is variable in the global market. According to a University of Alabama at Birmingham study, as reported in an article published in Sports Health in October 2019, the cost of orthobiologics therapy can range from a few hundred dollars to as much as $12,000. This price fluctuation adds a layer of complexity to the market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Ecosystem of the Market
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Orthobiologics Market by Product

• Market Overview
• Viscosupplementation Products
• Demineralized Bone Matrices
• Synthetic Orthobiologics
• Bone Morphogenic Protein
• Allografts
• Plasma-Rich Protein
• Bone Marrow Aspirate Concentrate

Orthobiologics Market by Application

• Market Overview
• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Soft-Tissue Injuries
• Fracture Recovery
• Maxillofacial and Dental Applications

Orthobiologics Market by End User

• Market Overview
• Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
• Research & Academic Institutes
• Dental Clinics and Facilities

Orthobiologics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix International N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seaspine Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alphatec Spine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthocell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bone Therapeutics SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments